Literature DB >> 16249831

Lipid peroxidation and trace elements in systemic sclerosis.

Mohammed Tikly1, Kalavati Channa, Penny Theodorou, Mairam Gulumian.   

Abstract

Oxidative stress appears to be important in the causation and perpetuation of tissue injury and fibrosis in systemic sclerosis or scleroderma (SSc). We conducted a case-control study to assess lipid peroxidation levels as determined by measuring fasting plasma malondialdehyde (MDA) and serum levels of the trace elements selenium, iron, zinc and copper in SSc. Plasma MDA levels were almost tenfold higher in patients than in controls (p=0.00007), and an inverse relationship between MDA levels and disease duration (r=-0.52, p=0.044) was observed. Selenium levels were lower in patients than in controls (p=0.012). Within the patient cohort, copper correlated inversely with the total skin score (r=-0.52, p=0.03). Our findings provide further evidence that lipid peroxidation is increased and antioxidant capacity is reduced in SSc. The gradual decline in MDA levels with time suggests that antioxidant therapy, if to be useful in SSc, is most likely to be effective early in the course of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249831     DOI: 10.1007/s10067-005-0013-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  26 in total

1.  Glutathione S-transferase genotypes in systemic sclerosis and their association with clinical manifestations in early disease.

Authors:  M B Tew; J D Reveille; F C Arnett; A W Friedman; T McNearney; M Fischbach; C Ahn; F K Tan
Journal:  Genes Immun       Date:  2001-06       Impact factor: 2.676

2.  Oxidative stress in Systemic Sclerosis.

Authors:  G Simonini; M M Cerinic; S Generini; M Zoppi; M Anichini; C Cesaretti; A Pignone; F Falcini; T Lotti; M Cagnoni
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

3.  A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis.

Authors:  A L Herrick; S Hollis; D Schofield; F Rieley; A Blann; K Griffin; T Moore; J M Braganza; M I Jayson
Journal:  Clin Exp Rheumatol       Date:  2000 May-Jun       Impact factor: 4.473

4.  Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma.

Authors:  C M Stein; S B Tanner; J A Awad; L J Roberts; J D Morrow
Journal:  Arthritis Rheum       Date:  1996-07

5.  The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.

Authors:  G Leonarduzzi; A Scavazza; F Biasi; E Chiarpotto; S Camandola; S Vogel; R Dargel; G Poli
Journal:  FASEB J       Date:  1997-09       Impact factor: 5.191

6.  Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.

Authors:  C P Denton; T D Bunce; M B Dorado; Z Roberts; H Wilson; K Howell; K R Bruckdorfer; C M Black
Journal:  Rheumatology (Oxford)       Date:  1999-04       Impact factor: 7.580

7.  Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury.

Authors:  R Solans; C Motta; R Solá; A E La Ville; J Lima; P Simeón; N Montellà; L Armadans-Gil; V Fonollosa; M Vilardell
Journal:  Arthritis Rheum       Date:  2000-04

Review 8.  Oxidative damage and fibrogenesis.

Authors:  G Poli; M Parola
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

9.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

10.  Dietary intake of micronutrient antioxidants in relation to blood levels in patients with systemic sclerosis.

Authors:  A L Herrick; H Worthington; F Rieley; D Clarke; D Schofield; J M Braganza; M I Jayson
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

View more
  11 in total

1.  Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.

Authors:  Alexandra Balbir-Gurman; Yolanda Braun-Moscovici; Vladimir Livshitz; Daniel Schapira; Doron Markovits; Alexander Rozin; Tatiana Boikaner; A Menahem Nahir
Journal:  Clin Rheumatol       Date:  2007-03-31       Impact factor: 2.980

Review 2.  Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.

Authors:  Marta Bueno; Anna Papazoglou; Eleanor Valenzi; Mauricio Rojas; Robert Lafyatis; Ana L Mora
Journal:  Curr Rheumatol Rep       Date:  2020-06-19       Impact factor: 4.592

Review 3.  Scleroderma therapy: clinical overview of current trends and future perspective.

Authors:  Afsha A Topal; Rachita S Dhurat
Journal:  Rheumatol Int       Date:  2012-08-03       Impact factor: 2.631

4.  Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis.

Authors:  Fumihide Ogawa; Kazuhiro Shimizu; Eiji Muroi; Toshihide Hara; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2011-02-16       Impact factor: 2.980

5.  Trace element levels in patients with familial mediterranean Fever.

Authors:  Kadir Yildirim; Hulya Uzkeser; Abdullah Uyanik; Saliha Karatay; Ahmet Kiziltunc
Journal:  Eurasian J Med       Date:  2011-08

6.  Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis.

Authors:  Esen Savas; Nur Aksoy; Yavuz Pehlivan; Zeynel Abidin Sayiner; Zeynel Abidin Oztürk; Suzan Tabur; Mustafa Orkmez; Ahmet Mesut Onat
Journal:  Wien Klin Wochenschr       Date:  2014-05-14       Impact factor: 1.704

Review 7.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 8.  Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited.

Authors:  Armando Gabrielli; Silvia Svegliati; Gianluca Moroncini; Giovanni Pomponio; Mariarosaria Santillo; Enrico V Avvedimento
Journal:  Semin Immunopathol       Date:  2008-06-12       Impact factor: 11.759

9.  Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants.

Authors:  Audrey Dooley; K Richard Bruckdorfer; David J Abraham
Journal:  Cardiol Res Pract       Date:  2011-10-31       Impact factor: 1.866

Review 10.  Oxidative stress in the pathogenesis of systemic scleroderma: An overview.

Authors:  Rosa Vona; Antonello Giovannetti; Lucrezia Gambardella; Walter Malorni; Donatella Pietraforte; Elisabetta Straface
Journal:  J Cell Mol Med       Date:  2018-04-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.